Viagra for women has been a topic of great debate ever since Pfizer Viagra first became available way back in 1998, approved for the treatment of erectile dysfunction.
However, that could be a reality by the end of next year as
scientists conduct trials on a new wonder drug that almost sounds like
it is too good to believe. Not only will be the tablet provide a boost
to the woman’s sex drive, but it will apparently also help to curb their
appetite and lose weight.
ORLIBID, the British company involved in
developing the drug, are optimistic they will be successful in having
‘ORL101’ on shelves by the end of 2015.
An estimated four in ten women complain at some point that their sex
life is larking the spark it once had and drug companies have toiled for
a number of years to create a female equivalent of the hugely popular
but still male-only Viagra – Pfizer’s sixth-biggest medicine, with
annual sales of about $2 billion (£1.22 billion).
A strong psychological factor linked to a woman’s libido makes it
difficult for pharmaceutical companies to create something effective and
beneficial.
Dr Mike Wyllie, part of the team behind the development of Viagra, is
of the opinion that ORLIBID could hold the key to unlocking the problem
of a woman’s sex drive, and possibly succeed where others have not.
Increasing the brain to desire, ORL101 is a synthetic version of
melatonin, which those with a penchant for tanning may have heard of.
Many experts have already been aware of melatonin’s ability to boost
sex drive, but the task of getting it into a pill, as opposed to an
injection, has proved a complex task.
The cost of ORL101 is anyone’s guess but it is assumed the drug will
be comparable to Viagra’s price when it initially launched; up to £12 a
tablet.
The tablet will only need to be taken 15 minutes prior to sex,
providing a boost to the woman’s libido for up to an impressive 2 hours.
This conclusion has been derived from studies conducted on jabs with
comparable formulas, which led to better sex and a decreased appetite
too.
Dr Wyllie is offering his services to ORLIBID on an advisory basis,
free of charge, and will not profit from sales. He says: “It will be for
everyone from those where female sexual dysfunction is destroying their
relationships to those just wanting to spice up their sex life.”
Dr John Dean, a former president of the International Society for
Sexual Medicine, said a drug could be ideal when no medical or
psychological cause for sexual problems is found.
He added: “Low sexual desire is by no means a trivial problem. It affects lives, relationships, productivity and satisfaction.”
No comments:
Post a Comment